Xconomy’s Digital Events →
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy